Minireviews
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Sep 16, 2014; 2(9): 426-431
Published online Sep 16, 2014. doi: 10.12998/wjcc.v2.i9.426
Clinical usefulness and current problems of pancreatic duct stenting for preventing post-ERCP pancreatitis
Yuji Sakai, Toshio Tsuyuguchi, Osamu Yokosuka
Yuji Sakai, Toshio Tsuyuguchi, Osamu Yokosuka, Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan
Author contributions: Sakai Y wrote the paper; Tsuyuguchi T and Yokosuka O revised the manuscript.
Correspondence to: Yuji Sakai, MD, Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Inohana 1-8-1, Chuou-ku, Chiba 260-8670, Japan. sakai4754@yahoo.co.jp
Telephone: +81-43-2262083 Fax: +81-43-2262088
Received: April 16, 2014
Revised: May 21, 2014
Accepted: June 27, 2014
Published online: September 16, 2014
Processing time: 161 Days and 23.8 Hours
Core Tip

Core tip: There are some patients who can avoid occurrence of post-endoscopic retrograde cholangiopancreatography pancreatitis (ERCP) pancreatitis by pancreatic duct stenting. However, it is impossible to prevent all post-ERCP pancreatitides by pancreatic duct stenting, and further examination will be needed.